Management of large submacular hemorrhage in a patient undergoing neurosurgical intervention for moyamoya
Article Sidebar
Main Article Content
Abstract
We report the case of a 30-year-old woman with diabetes and newly diagnosed moyamoya disease who experienced submacular hemorrhage and acute vision loss. She presented with facial droop and slurred speech, and examination disclosed high-grade stenosis of the intracranial carotid artery. She was scheduled for urgent neurosurgery. The day before surgery, she lost vision in her left eye and was found to have diffuse multilayered hemorrhage with submacular hemorrhage. Pneumatic displacement was performed. Pars plana vitrectomy and drainage of the submacular hemorrhage were performed subsequently, with postoperative improvement in vision.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med 2019;17:1977-84. DOI: https://doi.org/10.3892/etm.2019.7198
Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009;360:1226-37.
Wang X, Meng Y, Song D, Tan C, Wang G, Lv B, et al. Comparison of changes in retinal vascular parameters and density in patients with moyamoya disease: a retrospective study. Ophthalmic Res 2024;67:211-20. DOI: https://doi.org/10.1159/000538296
Katsman D, Klufas MA, Sarraf D, Sadda S. Retinal arterial tortuosity in moyamoya disease. JAMA Ophthalmol 2016;134:111-4. DOI: https://doi.org/10.1001/jamaophthalmol.2015.4645
Ashik R, Pal S, Patidar N, Gabba HS, Gaikwad H. Subconjunctival and perioptic vascular lesion in asymptomatic moyamoya disease—a rare ocular presentation. Neurol India 2023;71:802-3. DOI: https://doi.org/10.4103/0028-3886.383829
Lo K-J, Wang A-G, Cheng H-C. Retinal vasculature changes after bypass surgery for moyamoya disease. Ophthalmology 2021;128:120. DOI: https://doi.org/10.1016/j.ophtha.2020.08.014
Li Y, Yan Z, Shi P, Feng W, Liu J, Wang L. Retinal branch artery occlusion combined with moyamoya disease in young adult. Minerva Pediatr (Torino) 2023;75:764-6. DOI: https://doi.org/10.23736/S2724-5276.23.07304-4
Lad EM, Lad SP, Ung C, Jain A, Steinberg GK, Gaynon MW. Complete visual recovery after incipient crao due to ocular hypoperfusion in a patient with moyamoya disease. Retin Cases Brief Rep 2013;7:248-51. DOI: https://doi.org/10.1097/ICB.0b013e31828eef20
Wang Y-Y, Zhou K-Y, Ye Y, et al. Moyamoya disease associated with morning glory disc anomaly and other ophthalmic findings: a mini-review. Front Neurol 2020;11:338. DOI: https://doi.org/10.3389/fneur.2020.00338
Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996;16:183-9. DOI: https://doi.org/10.1097/00006982-199616030-00001
Mun Y, Park KH, Park SJ, et al. Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy. Sci Rep 2022;12:14875. DOI: https://doi.org/10.1038/s41598-022-18619-5
Das D, Handique SK, Bhattacharjee H, et al. Moyamoya disease with neuro-ophthalmic manifestations: a rare case report. Eye Brain 2010;2:63-5.
Kim H, Lee SC, Kim SM, et al. Identification of underlying causes of spontaneous submacular hemorrhage by indocyanine green angiography. Ophthalmologica 2015;233:146-54. DOI: https://doi.org/10.1159/000380830
Takebayashi S, Matsuo K, Kaneko M. Ultrastructural studies of cerebral arteries and collateral vessels in moyamoya disease. Stroke 1984;15:728-32. DOI: https://doi.org/10.1161/01.STR.15.4.728
Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke Cerebrovasc Dis 2016;18:2-11. DOI: https://doi.org/10.5853/jos.2015.01627
Das D, Handique SK, Bhattacharjee H, et al. Moyamoya disease with neuro-ophthalmic manifestations: a rare case report. Eye Brain 2010;2:63-5. DOI: https://doi.org/10.2147/EB.S7614
Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009;360: 1226-37. DOI: https://doi.org/10.1056/NEJMra0804622
Kumar M A, Ganesh B A. CRAO in Moyamoya disease. J Clin Diagn Res 2013;7:545-7.
Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999;106:1900-907. DOI: https://doi.org/10.1016/S0161-6420(99)90399-8
Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1998;116:1326-32. DOI: https://doi.org/10.1001/archopht.116.10.1326
Gopalakrishan M, Giridhar A, Bhat S, Saikumar SJ, Elias A, N S. Pneumatic displacement of submacular hemorrhage: safety, efficacy, and patient selection. Retina 2007;27:329-34. DOI: https://doi.org/10.1097/01.iae.0000231544.43093.40
Fang I-M, Lin Y-C, Yang C-H, Yang C-M, Chen M-S. Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration. Eye 2009;23:397-406. DOI: https://doi.org/10.1038/sj.eye.6703017
Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol 1999;128:739-46. DOI: https://doi.org/10.1016/S0002-9394(99)00239-1
Kim HS, Cho HJ, Yoo SG, et al. Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration. Eye 2015;29:1141-51. DOI: https://doi.org/10.1038/eye.2015.131
Maruyama-Inoue M, Kitajima Y, Yanagi Y, Inoue T, Kadonosono K. Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage. Sci Rep 2023;13:5688. DOI: https://doi.org/10.1038/s41598-023-32874-0
Shienbaum G, Garcia Filho CAA, Flynn HW Jr, Nunes RP, Smiddy WE, Rosenfeld PJ. Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy. Am J Ophthalmol 2013;155:1009-13. DOI: https://doi.org/10.1016/j.ajo.2013.01.012
Jain S, Kishore K, Sharma YR. Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration. Indian J Ophthalmol 2013;61:490-96. DOI: https://doi.org/10.4103/0301-4738.119432
Shin JY, Lee J-M, Byeon SH. Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage. Am J Ophthalmol 2015;159:904-14.e1. DOI: https://doi.org/10.1016/j.ajo.2015.01.024
Chang W, Garg SJ, Maturi R, et al. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol 2014;157:1250-57. DOI: https://doi.org/10.1016/j.ajo.2014.02.007
Ogata M, Oh H, Nakata A, et al. Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator. Sci Rep 2022;12:22139. DOI: https://doi.org/10.1038/s41598-022-26289-6
Chew GWM, Ivanova T, Patton N, et al. Step-wise approach to the management of submacular hemorrhage using pneumatic displacement and vitrectomy: the Manchester protocol. Retina 2022;42:11-18. DOI: https://doi.org/10.1097/IAE.0000000000003294